ArticleProceedings of the National Academy of Sciences of the United States of America1998

Cdkn2a, the cyclin-dependent kinase inhibitor encoding p16INK4a and p19ARF, is a candidate for the plasmacytoma susceptibility locus, Pctr1.

S Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.